2024-12-01 2025-11-30 false Capium Accounts Production 1.1 14468857 2024-12-01 2025-11-30 14468857 bus:AbridgedAccounts 2024-12-01 2025-11-30 14468857 bus:FRS102 2024-12-01 2025-11-30 14468857 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 14468857 bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 14468857 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 14468857 2024-12-01 2025-11-30 14468857 2025-11-30 14468857 bus:RegisteredOffice 2024-12-01 2025-11-30 14468857 core:WithinOneYear 2025-11-30 14468857 core:AfterOneYear 2025-11-30 14468857 1 2024-12-01 2025-11-30 14468857 bus:Director1 2024-12-01 2025-11-30 14468857 bus:Director1 2025-11-30 14468857 bus:Director1 2023-12-01 2024-11-30 14468857 bus:Director2 2024-12-01 2025-11-30 14468857 bus:Director2 2025-11-30 14468857 bus:Director2 2023-12-01 2024-11-30 14468857 bus:Director3 2024-12-01 2025-11-30 14468857 bus:Director3 2025-11-30 14468857 bus:Director3 2023-12-01 2024-11-30 14468857 2023-12-01 14468857 bus:LeadAgentIfApplicable 2024-12-01 2025-11-30 14468857 2023-12-01 2024-11-30 14468857 2024-11-30 14468857 core:WithinOneYear 2024-11-30 14468857 core:AfterOneYear 2024-11-30 14468857 bus:EntityAccountantsOrAuditors 2023-12-01 2024-11-30 14468857 bus:OrdinaryShareClass1 2024-12-01 2025-11-30 14468857 bus:OrdinaryShareClass1 2025-11-30 14468857 bus:OrdinaryShareClass1 2023-12-01 2024-11-30 14468857 bus:OrdinaryShareClass1 2024-11-30 14468857 core:OtherResidualIntangibleAssets 2024-12-01 2025-11-30 14468857 core:OtherResidualIntangibleAssets 2025-11-30 14468857 core:OtherResidualIntangibleAssets 2024-11-30 14468857 core:CostValuation core:Non-currentFinancialInstruments 2025-11-30 14468857 core:CostValuation core:Non-currentFinancialInstruments 2024-11-30 14468857 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-11-30 14468857 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 14468857 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 14468857 core:Non-currentFinancialInstruments 2025-11-30 14468857 core:Non-currentFinancialInstruments 2024-11-30 14468857 core:ShareCapital 2025-11-30 14468857 core:ShareCapital 2024-11-30 14468857 core:RetainedEarningsAccumulatedLosses 2025-11-30 14468857 core:RetainedEarningsAccumulatedLosses 2024-11-30 14468857 dpl:Item1 2024-12-01 14468857 dpl:Item1 2025-11-30 14468857 dpl:Item1 2023-12-01 14468857 dpl:Item1 2024-11-30 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 14468857
England and Wales
BP MED LIMITED
Abridged Accounts
Period of accounts Start date: 01 December 2024 End date: 30 November 2025

BP MED LIMITED Contents Page For the year ended 30 November 2025
Accountants' report | 1
Statement of financial position | 2
Notes to the financial statements | 3

BP MED LIMITED Accountants' Report For the year ended 30 November 2025
Accountant’s report You consider that the company is exempt from an audit for the year ended 30 November 2025 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year. In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us. We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts. HPJ Accountancy & Consultancy Ltd. 30 November 2025 .................................................... HPJ Accountancy & Consultancy Ltd. Suite 5.6, 5th Floor Standard Buildings 94 Hope Street Glasgow G2 6PH 06 February 2026 1

BP MED LIMITED Statement of Financial Position As at 30 November 2025
| Notes | 2025 £ |  | 2024 £
--- | --- | --- | --- | ---
Fixed assets |  |  |
Intangible fixed assets | 3 | 1,077 |  | 1,077
|  | 1,077 |  | 1,077
Current assets |  |  |
Debtors |  | 16,869 |  | 4,070
Cash at bank and in hand |  | 19,204 |  | 17,685
|  | 36,073 |  | 21,755
Creditors: amount falling due within one year |  | (23,502) |  | (16,349)
Net current assets |  | 12,571 |  | 5,406
Total assets less current liabilities |  | 13,648 |  | 6,483
Net assets |  | 13,648 |  | 6,483
Capital and reserves |  |  |
Called up share capital | 4 | 100 |  | 100
Profit and loss account |  | 13,548 |  | 6,383
Shareholders' funds |  | 13,648 |  | 6,483
For the year ended 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Directors' responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies. The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A). The financial statements were approved by the board of directors on 06 February 2026 and were signed on its behalf by:
------------------------------- Jeevanand Muniandy Director
2

BP MED LIMITED Notes to the Abridged Financial Statements For the year ended 30 November 2025
General Information BP MED LIMITED is a private company, limited by shares, registered in England and Wales, registration number 14468857, registration address Unit 12 Lloyd Street North, Manchester Science Park, Manchester, M15 6SE. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Taxation Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Current and deferred tax assets and liabilities are not discounted Intangible assets Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable. Tangible fixed assets Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis: Office Equipment are depreciated at 25% Reducing Balance Method.
2. | Average number of employees There was one employee during the period under review Average number of employees during the year was 1 (2024 : 3).
3. | Intangible fixed assets
Cost | Other |  | Total
| £ |  | £
At 01 December 2024 | 1,260 |  | 1,260
Additions | - |  | -
Disposals | - |  | -
At 30 November 2025 | 1,260 |  | 1,260
Amortisation
At 01 December 2024 | 183 |  | 183
Charge for year | - |  | -
On disposals | - |  | -
At 30 November 2025 | 183 |  | 183
Net book values
At 30 November 2025 | 1,077 |  | 1,077
At 30 November 2024 | 1,077 |  | 1,077
4. | Share Capital
Allotted, called up and fully paid | 2025 £ |  | 2024 £
--- | --- | --- | ---
100 Class A shares of £1.00 each | 100 |  | 100
| 100 |  | 100
3